• 1
    Shopland DR, Eyre HJ, Pechacek TF: Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 1991; 83: 11421148.
  • 2
    Takkouche B, Gastal-Otero JJ: The epidemiology of lung cancer: Review of risk factors and Spanish data. Eur J Epidemiol 1996; 12: 341349.
  • 3
    Ziegler RG, Mayne ST, Swanson CA: Nutrition and lung cancer. Cancer Causes Control 1996; 7: 157177.
  • 4
    Greenblatt MS, Harris CC: Molecular genetics of lung cancer. Cancer Surv 1995; 25: 293313.
  • 5
    Morabia A, Sorenson A, Kumanyika SK, et al: Vitamin A, cigarette smoking, and airway obstruction. American Review of Respiratory Diseases 1989; 140: 13121316.
  • 6
    Jetten AM, Vollberg TM, Nervi C, et al: Positive and negative regulation of proliferation and differentiation in tracheobronchial epithelial cells. American Review of Respiratory Diseases 1990; 142 (Suppl): S36S39.
  • 7
    Reynolds P, Fontham ET: Passive smoking and lung cancer. Ann Med 1995; 27: 633640.
  • 8
    Albanes D, Heinonen OP, Taylor PR et al: Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 15601570.
  • 9
    Omenn GS, Goodman GE, Thornquist MD, et al: Risk factors for lung cancer and for intervention effects in CARET, the beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 15501559.
  • 10
    Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 10291035.
  • 11
    van Poppel G, Goldbohm RA: Epidemiologic evidence for beta-carotene and cancer prevention. Am J Clin Nutr 1995; 62 (Suppl 6): 1393S1402S.
  • 12
    Reilly M, Delanty N, Lawson JA, et al: Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 1925.
  • 13
    Hilbert J, Mohsenin V: Adaptation of lung antioxidants to cigarette smoking in humans. Chest 1996; 110: 916920.
  • 14
    Santamaria L, Bianchi A: Cancer chemoprevention by supplemental carotenoids in animals and humans. Prev Med 1989; 18: 603623.
  • 15
    Nishino H: Cancer chemoprevention by natural carotenoids and their related compounds. J Cell Biochem 1995 (Suppl) 22: 231235.
  • 16
    Rock CL, Kusluski RA, Galvez MM, et al: Carotenoids induce morphological changes in human mammary epithelial cell cultures. Nutr Cancer 1995; 23: 319333.
  • 17
    Okai Y, Higashi-Okai K, Nakamura S, et al: Suppressive effects of retinoids, carotenoids and antioxidant vitamins on heterocyclic amine-inducedumu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002). Mutat Res 1996; 368: 133140.
  • 18
    Block E, Naganathan S, Putman D, et al: Organosulfur chemistry of garlic and onion: Recent results. Pure Applied Chemistry 1993; 65: 626632.
  • 19
    Stoner GD, Mandal-Chaudhuti S, Daniel EM, et al: Chemoprevention of esophageal cancer by ellagic acid and phenethyl isothiocyanate, in WattenbergL, LipkinM, BooneCW, et al (eds): Cancer Chemoprevention. Boca Raton, FL, CRC Press, 1992, pp 407439.
  • 20
    Stoner GD, Mukhtar H: Polyphenols as cancer chemopreventive agents. J Cell Biochem 1995; 22 (Suppl): 169180.
  • 21
    Jovanovic SV, Steenken S, Hara Y, et al: Reduction potentials of flavonoid and model phenoxyl radicals. Which ring in flavonoids is responsible for antioxidant activity?. J Chem Soc, Perkin Transactions II 1996; 2: 497504.
  • 22
    Foti M, Piattelli M, Barratta MT, et al: Flavonoids, coumarins and cinnamic acids as antioxidants in a micellar system. Structure-activity relationship. J Agricultural Food Chem 1996; 44: 497501.
  • 23
    Keohavong P, DeMichele MA, Melacrinos AC, et al: Detection of K-ras mutations in lung carcinomas: Relationship to prognosis. Clinical Cancer Res 1996; 2: 411418.
  • 24
    Yang CS, Brady JF, Hong JY: Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity. FASEB J 1992; 6: 737744.
  • 25
    Huang MT, Lysz T, Ferraro T, et al: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 1991; 51: 813819.
  • 26
    Chan MMY, Fong D: Anti-inflammatory and cancer-preventive immunomodulation through diet, in HoCT, OsawaT, HuangMT, et al (eds): Food Phytochemicals for Cancer Prevention II: Teas, Spices, and Herbs. Washington, DC, American Chemical Society, 1994, pp 221230.
  • 27
    Santos MS, Meydani SN, Leka L, et al: Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation. Am J Clin Nutr 1996; 64: 772777.
  • 28
    Biesalski HK, Weiser H: Beta-carotene supplements cannot meet all vitamin A requirements of vitamin A-deficient rats. Ann NY Acad Sci 1993; 691: 216219.
  • 29
    Jetten AM, Rearick JL, Smits HL: Regulation of differentiation of airway epithelial cells by retinoids. Biochem Soc Trans 1986; 14: 930933.
  • 30
    Lotan R: Retinoids in cancer chemoprevention. FASEB J 1996; 10: 10311039.
  • 31
    Xu MX, Peng YM, Liu Y: Effect of chronic oral administration of beta-carotene on plasma alphatocopherol concentrations in normal subjects. Proc Am Assoc Cancer Res 1990; 31: 126. Abstract.
  • 32
    Xu MJ, Plezia PM, Alberts DS, et al: Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice. J Natl Cancer Inst 1992; 84: 15591565.
  • 33
    Slaughter DP, Southwick HW, Smejkal W: “Field cancerization” in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer 1953; 6: 963968.
  • 34
    Pastorino U, Infante M, Maioli M, et al: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11: 12161222.
  • 35
    Hong WK, Lippman SM, Itr LM, et al: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795801.
  • 36
    de Vries N, van Zandwijk N, Pastorino U: The EUROSCAN Study. Br J Cancer 1991; 64: 985989.
  • 37
    Lippman SM, Benner SE, Hong WK: Chemoprevention strategies in lung carcinogenesis. Chest 1993; 103 (Suppl 1): 15S19S.
  • 38
    Lee JS, Lippman SM, Hong WK, et al: Determination of biomarkers for intermediate end points in chemoprevention trials. Cancer Res 1992; 52 (Suppl 9): 2707S2710S.